Literature DB >> 15497021

Thrombosis-free surgical procedures in severe (Homozygote) factor XII deficiency: report of four additional cases and literature review.

A Girolami1, E Ruzzon, A M Lombardi, L Cabrio, M L Randi.   

Abstract

The outcome of various surgical procedures carried out in patients with severe (homozygote) factor XII deficiency were investigated for the appearance of blood coagulation-related complications with particular emphasis on thrombotic complications. The surgical procedures were total mastectomy, tonsillectomy and adenoidectomy, placement of a hip prosthesis, and double hernia repair. None of the patients slowed any complication. Several other reported cases of surgical procedures carried out in several patients ware found in the literature. Bleeding or thrombotic complications were noted in none of these cases. The surgical procedures in some cases were minor such as adenoidectomy, tonsillectomy, or nasal polyp removal. However several major surgical procedures were carried out in some patients (cholecystectomy, gastrectomy, repair of atrial septal defect, coronary bypass). All patients remained asymptomatic. In some cases whole blood and/or plasma were used as requested by the caring surgeons. In a few patients, the plasma was given prophylactically because of the long partial thromboplastin time. Finally, three patients (two for cardiac surgery and one after hip replacement) received heparin prophylaxis as foreseen by accepted procedures without the undue sequels. These data supply further evidence that factor XII deficiency does not only show any bleeding tendency but also can withstand even major surgical procedures without thrombotic complications.

Entities:  

Mesh:

Year:  2004        PMID: 15497021     DOI: 10.1177/107602960401000407

Source DB:  PubMed          Journal:  Clin Appl Thromb Hemost        ISSN: 1076-0296            Impact factor:   2.389


  7 in total

1.  Rapid development of chylothorax in patient with propofol-induced coma.

Authors:  Krzysztof Laudanski; A Joseph Layon
Journal:  BMJ Case Rep       Date:  2009-07-14

Review 2.  Pregnancies and oral contraceptive therapy in severe (homozygons) FXII deficiency: a study in 12 patients and review of the literature.

Authors:  A Girolami; N Zocca; B Girolami; A M Lombardi; F Fabris
Journal:  J Thromb Thrombolysis       Date:  2004-12       Impact factor: 2.300

3.  Prolonged activated partial thromboplastin time secondary to factor XII deficiency in two surgical patients.

Authors:  Bushra Moiz; Muhammed Wahhaab Sadiq; Muhammad Abdullah Javed; Baqir Hasan Jafry; Muhammad Anees
Journal:  Oxf Med Case Reports       Date:  2021-03-08

4.  Defective thrombus formation in mice lacking coagulation factor XII.

Authors:  Thomas Renné; Miroslava Pozgajová; Sabine Grüner; Kai Schuh; Hans-Ulrich Pauer; Peter Burfeind; David Gailani; Bernhard Nieswandt
Journal:  J Exp Med       Date:  2005-07-11       Impact factor: 14.307

5.  Production and control of coagulation proteins for factor X activation in human endothelial cells and fibroblasts.

Authors:  Clay T Cohen; Nancy A Turner; Joel L Moake
Journal:  Sci Rep       Date:  2020-02-06       Impact factor: 4.379

6.  Factor XII deficiency in asymptomatic Saudi population: A retrospective cohort study.

Authors:  Fatmah S Alqahtany; Farjah H Algahtani; Mashael M Alshebly; Thamer S Albegamy; Essam S Alghamdi; Mohammed A Alnakhli; Fatimah M Madkhaly; Abdullah A Alharbi; Nawaf A Alqahtani
Journal:  Saudi J Biol Sci       Date:  2021-01-08       Impact factor: 4.219

7.  A phase I, first-in-human, randomized dose-escalation study of anti-activated factor XII monoclonal antibody garadacimab.

Authors:  Andrew McKenzie; Anthony Roberts; Sourabh Malandkar; Henrike Feuersenger; Con Panousis; Dipti Pawaskar
Journal:  Clin Transl Sci       Date:  2021-12-03       Impact factor: 4.689

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.